CVS CEO defends PBMS, accuses manufacturers of 'monopolistic' practice medicines
David Joyner, a CVS Executive for a long time, speaks during an audience of the Health, Education, Labor and Pensions…
Biotechnology
CVS HEALTH (CVS) Q4 2024
CVS health On Wednesday, he reported income and profits of the fourth quarter that overcame estimates, even when his problems…
Modern (RNM) Q4 Gains 2024
Modern on Friday registered income from the fourth quarter that exceeded the estimates, but lost more than expected by the…
CVS gains: (CVS) increases shares
The CVS pharmacy logo is shown on a sign on a CVS Health Corp. store in Las Vegas, Nevada, on…
Biogen profits (BIIB) Q4 2024
A test tube is observed in front of the biogen logo shown in this illustration taken on December 1, 2021.…
ELI LILY (LLY) Q4 2024 earnings
Eli Lilly reported mixed results for the fourth quarter on Thursday, even when the demand for its great success of…
Trump could make changes to Medicare drug price negotiations
President Donald Trump arrives at the Brady Press room at the White House on January 30, 2025 in Washington, DC.…
Merck profits (MRK) Q4 2024
Soup images | LIGHTROCKET | Getty images Merck On Tuesday, he issued an income guide of 2025 per full year…
Trump's tariffs could increase drug costs, worsen scarcity
Shana Novak | Stone | Getty images President Donald Trump's pronounced tariffs on Canada, Mexico and China could worsen the…
Novo Nordisk Ozempic wins FDA approval for chronic kidney disease
Food and medication administration approved Tuesday Novo Nordisk'S Ozempic to treat chronic kidney disease in patients who also have type…